Sumitomo Mitsui DS Asset Management’s Moderna MRNA Stock Holding History

Sumitomo Mitsui DS Asset Management’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$836K	Buy	11,938 +1,415	+13%	+$73.2K	0.01%	643
2026 Q1	$535K	Buy	10,523 +1,592	+18%	+$74.3K	﹤0.01%	665
2025 Q4	$263K	Hold	8,931	–	–	﹤0.01%	722
2025 Q3	$231K	Hold	8,931	–	–	﹤0.01%	730
2025 Q2	$246K	Sell	8,931 -26,032	-74%	-$686K	﹤0.01%	716
2025 Q1	$991K	Buy	34,963 +100	+0.3%	+$3.55K	0.01%	627
2024 Q4	$1.45M	Buy	34,863 +657	+2%	+$31.4K	0.01%	557
2024 Q3	$2.29M	Buy	34,206 +746	+2%	+$68.5K	0.02%	443
2024 Q2	$3.97M	Buy	33,460 +685	+2%	+$86.7K	0.05%	299
2024 Q1	$3.49M	Buy	32,775 +3,806	+13%	+$384K	0.04%	328
2023 Q4	$2.88M	Buy	28,969 +306	+1%	+$25.7K	0.04%	376
2023 Q3	$2.96M	Buy	28,663 +279	+1%	+$31.1K	0.05%	314
2023 Q2	$3.45M	Buy	28,384 +2,042	+8%	+$272K	0.05%	285
2023 Q1	$4.05M	Buy	26,342 +293	+1%	+$48.3K	0.07%	223
2022 Q4	$4.68M	Buy	26,049 +1,489	+6%	+$243K	0.09%	179
2022 Q3	$2.9M	Buy	24,560 +1,365	+6%	+$207K	0.07%	245
2022 Q2	$3.31M	Buy	23,195 +794	+4%	+$113K	0.08%	213
2022 Q1	$3.86M	Buy	22,401 +43	+0.2%	+$7.24K	0.08%	206
2021 Q4	$5.68M	Buy	22,358 +76	+0.3%	+$22.2K	0.12%	156
2021 Q3	$8.57M	Buy	22,282 +3,418	+18%	+$1.26M	0.2%	102
2021 Q2	$4.43M	Buy	18,864 +3,306	+21%	+$591K	0.11%	181
2021 Q1	$2.04M	Buy	15,558 +96	+0.6%	+$13.9K	0.05%	307
2020 Q4	$1.61M	Sell	15,462 -41	-0.3%	-$4.15K	0.05%	343
2020 Q3	$1.1M	Buy	15,503 +12	+0.1%	+$837	0.03%	392
2020 Q2	$994K	Buy	+15,491	New	+$848K	0.03%	396

Other funds holding MRNA

BPC

Banque Pictet & Cie Geneva 73, Switzerland $16B AUM 29.1% 1-Year Est. Return

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

OIAM

OFI Invest Asset Management Paris, France $10B AUM 48.47% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

CNB

Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

COPPSERS

Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

CUAMC

China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

Sumitomo Mitsui DS Asset Management's MRNA Position: Q2 2026 in Review

Sumitomo Mitsui DS Asset Management increased its Moderna (MRNA) stake by 13% in Q2 2026, buying an estimated $73.2K and bringing the position to 11,938 shares worth $836K. The position accounts for 0.01% of the portfolio, ranked #643.

Sumitomo Mitsui DS Asset Management first reported a position in MRNA in Q2 2020 and has held it in 25 quarters since. The position peaked at $8.57M in Q3 2021. 184 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

Sumitomo Mitsui DS Asset Management held 11,938 shares of Moderna worth $836K as of Q2 2026.
Sumitomo Mitsui DS Asset Management bought 1,415 Moderna shares in Q2 2026, an estimated $73.2K.
Moderna made up 0.01% of Sumitomo Mitsui DS Asset Management's portfolio in Q2 2026, its #643 holding.
Sumitomo Mitsui DS Asset Management first reported a position in Moderna in Q2 2020 and has held it in 25 quarters since.
Sumitomo Mitsui DS Asset Management's Moderna position peaked at $8.57M in Q3 2021.
184 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Sumitomo Mitsui DS Asset Management's 13F filing for Q2 2026, filed 22 Jul 2026.